Tenax Therapeutics TENX
NASDAQ TENX
$1.93 +0.04 (+2.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Preferred Stock Liabilities (2012)

Updated

Tenax Therapeutics' Preferred Stock Liabilities was $429,978 in Q2 2013, down 78.9% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Preferred Stock Liabilities (2012) Analysis & Trends

At the end of FY2012, Preferred Stock Liabilities at Tenax Therapeutics came in at $1.25 million.

  • Per Business Quant data, TENX's Preferred Stock Liabilities in the three quarters before Q2 2013 was $2.04 million (Q1 2013), $1.25 million (Q4 2012) and $3.92 million (Q3 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tenax Therapeutics 85.48 Mn 85.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 429,978.00
Jul 31, 2012 2.04 Mn
Apr 30, 2012 1.25 Mn
Jan 31, 2012 3.92 Mn
API Access

Tenax Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TENX&period=max&api_key=YOUR_API_KEY